Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.2 - $17.76 $11,008 - $14,811
834 Added 3.02%
28,407 $504,000
Q4 2023

Feb 13, 2024

BUY
$6.52 - $20.32 $38,631 - $120,396
5,925 Added 27.37%
27,573 $518,000
Q3 2023

Nov 13, 2023

BUY
$6.02 - $7.76 $48,129 - $62,041
7,995 Added 58.56%
21,648 $153,000
Q2 2023

Aug 04, 2023

BUY
$5.79 - $9.11 $79,050 - $124,378
13,653 New
13,653 $102,000
Q2 2022

Aug 12, 2022

SELL
$4.66 - $13.96 $65,328 - $195,705
-14,019 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$11.89 - $24.68 $11,747 - $24,383
-988 Reduced 6.58%
14,019 $181,000
Q4 2021

Feb 11, 2022

SELL
$24.14 - $35.18 $3,234 - $4,714
-134 Reduced 0.89%
15,007 $373,000
Q3 2021

Nov 12, 2021

SELL
$27.38 - $42.21 $9,829 - $15,153
-359 Reduced 2.32%
15,141 $500,000
Q2 2021

Aug 13, 2021

BUY
$26.34 - $46.62 $15,619 - $27,645
593 Added 3.98%
15,500 $448,000
Q1 2021

May 07, 2021

BUY
$45.96 - $68.02 $1,792 - $2,652
39 Added 0.26%
14,907 $755,000
Q4 2020

Feb 12, 2021

BUY
$13.72 - $51.57 $17,643 - $66,319
1,286 Added 9.47%
14,868 $722,000
Q3 2020

Nov 04, 2020

SELL
$10.54 - $18.47 $3,256 - $5,707
-309 Reduced 2.22%
13,582 $240,000
Q2 2020

Aug 12, 2020

BUY
$10.37 - $20.64 $36,295 - $72,240
3,500 Added 33.68%
13,891 $253,000
Q1 2020

May 04, 2020

SELL
$9.63 - $17.14 $5,768 - $10,266
-599 Reduced 5.45%
10,391 $126,000
Q4 2019

Feb 05, 2020

SELL
$7.2 - $13.2 $669 - $1,227
-93 Reduced 0.84%
10,990 $145,000
Q3 2019

Nov 08, 2019

BUY
$8.95 - $15.72 $10,963 - $19,257
1,225 Added 12.43%
11,083 $99,000
Q2 2019

Aug 13, 2019

BUY
$14.61 - $22.45 $5,230 - $8,037
358 Added 3.77%
9,858 $156,000
Q1 2019

May 06, 2019

BUY
$14.24 - $22.28 $76,938 - $120,378
5,403 Added 131.88%
9,500 $179,000
Q4 2018

Feb 13, 2019

SELL
$17.86 - $28.77 $553 - $891
-31 Reduced 0.75%
4,097 $94,000
Q3 2018

Nov 09, 2018

BUY
$13.39 - $26.25 $55,273 - $108,360
4,128 New
4,128 $106,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.